Cabanu, S.; Pilar-Cuéllar, F.; Zubakina, P.; Florensa-Zanuy, E.; Senserrich, J.; Newman-Tancredi, A.; Adell, A.
Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT1A Receptor Biased Agonist. Pharmaceuticals 2022, 15, 337.
https://doi.org/10.3390/ph15030337
AMA Style
Cabanu S, Pilar-Cuéllar F, Zubakina P, Florensa-Zanuy E, Senserrich J, Newman-Tancredi A, Adell A.
Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT1A Receptor Biased Agonist. Pharmaceuticals. 2022; 15(3):337.
https://doi.org/10.3390/ph15030337
Chicago/Turabian Style
Cabanu, Sharon, Fuencisla Pilar-Cuéllar, Paula Zubakina, Eva Florensa-Zanuy, Júlia Senserrich, Adrian Newman-Tancredi, and Albert Adell.
2022. "Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT1A Receptor Biased Agonist" Pharmaceuticals 15, no. 3: 337.
https://doi.org/10.3390/ph15030337
APA Style
Cabanu, S., Pilar-Cuéllar, F., Zubakina, P., Florensa-Zanuy, E., Senserrich, J., Newman-Tancredi, A., & Adell, A.
(2022). Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT1A Receptor Biased Agonist. Pharmaceuticals, 15(3), 337.
https://doi.org/10.3390/ph15030337
